Peripheral blood vessels are a niche for blood-borne meningococci

ABSTRACT Neisseria meningitidis is the causative agent of cerebrospinal meningitis and that of a rapidly progressing fatal septic shock known as purpura fulminans. Meningococcemia is characterized by bacterial adhesion to human endothelial cells of the microvessels. Host specificity has hampered studies on the role of blood vessels colonization in N. meningitidis associated pathogenesis. In this work, using a humanized model of SCID mice allowing the study of bacterial adhesion to human cells in an in vivo context we demonstrate that meningococcal colonization of human blood vessels is a prerequisite to the establishment of sepsis and lethality. To identify the molecular pathways involved in bacterial virulence, we performed transposon insertion site sequencing (Tn-seq) in vivo. Our results demonstrate that 36% of the genes that are important for growth in the blood of mice are dispensable when bacteria colonize human blood vessels, suggesting that human endothelial cells lining the blood vessels are feeding niches for N. meningitidis in vivo. Altogether, our work proposes a new paradigm for meningococcal virulence in which colonization of blood vessels is associated with metabolic adaptation and sustained bacteremia responsible for sepsis and subsequent lethality.

[1]  X. Nassif,et al.  Pathogenesis of meningococcal purpura fulminans. , 2017, Pathogens and disease.

[2]  S. Bourdoulous,et al.  A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers , 2017, Nature Reviews Microbiology.

[3]  Aldert L. Zomer,et al.  Comprehensive Identification of Meningococcal Genes and Small Noncoding RNAs Required for Host Cell Colonization , 2016, mBio.

[4]  P. Kohl,et al.  A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria , 2016, Nature Communications.

[5]  Narmada Thanki,et al.  CDD: NCBI's conserved domain database , 2014, Nucleic Acids Res..

[6]  Johannes Elias,et al.  Metabolism and virulence in Neisseria meningitidis , 2014, Front. Cell. Infect. Microbiol..

[7]  E. Chevet,et al.  Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization , 2014, Nature Medicine.

[8]  R. Read.  Neisseria meningitidis; clones, carriage, and disease. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  X. Nassif,et al.  Meningococcal interaction to microvasculature triggers the tissular lesions of purpura fulminans. , 2013, The Journal of infectious diseases.

[10]  K. Melican,et al.  A humanized model of microvascular infection. , 2013, Future microbiology.

[11]  P. Bruneval,et al.  Adhesion of Neisseria meningitidis to Dermal Vessels Leads to Local Vascular Damage and Purpura in a Humanized Mouse Model , 2013, PLoS pathogens.

[12]  S. V. van Hijum,et al.  ESSENTIALS: Software for Rapid Analysis of High Throughput Transposon Insertion Sequencing Data , 2012, PloS one.

[13]  M. Vacher-Lavenu,et al.  Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Ahmad A Mannan,et al.  Interrogation of global mutagenesis data with a genome scale model of Neisseria meningitidis to assess gene fitness in vitro and in sera , 2011, Genome Biology.

[15]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[16]  P. François,et al.  Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival , 2011, PLoS pathogens.

[17]  S. Bentley,et al.  Genotypic and Phenotypic Modifications of Neisseria meningitidis after an Accidental Human Passage , 2011, PloS one.

[18]  R. Schwarz,et al.  Comparative Genome Biology of a Serogroup B Carriage and Disease Strain Supports a Polygenic Nature of Meningococcal Virulence , 2010, Journal of bacteriology.

[19]  D. Levy-bruhl,et al.  Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France. , 2010, The Journal of infectious diseases.

[20]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[21]  Carmen Buchrieser,et al.  NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis , 2009, Genome Biology.

[22]  Georgia Giannoukos,et al.  Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung , 2009, Proceedings of the National Academy of Sciences.

[23]  R. Exley,et al.  Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. , 2009, The Lancet. Infectious diseases.

[24]  David H Perlman,et al.  The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance , 2006, The Journal of Immunology.

[25]  P. Couraud,et al.  Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures , 2006, The Journal of cell biology.

[26]  R. Read,et al.  Neisseria meningitidis Lactate Permease Is Required for Nasopharyngeal Colonization , 2005, Infection and Immunity.

[27]  P. Brandtzaeg,et al.  Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease , 2005, Journal of Clinical Microbiology.

[28]  S. Faust,et al.  Ethics of antenatal screening for Down’s syndrome , 2003, Archives of disease in childhood.

[29]  X. Nassif,et al.  Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. , 2003, Genome research.

[30]  L. A. Lewis,et al.  Interactions of haemoglobin with the Neisseria meningitidis receptor HpuAB: the role of TonB and an intact proton motive force , 2002, Molecular microbiology.

[31]  X. Nassif,et al.  The adhesive property of the type IV pilus‐associated component PilC1 of pathogenic Neisseria is supported by the conformational structure of the N‐terminal part of the molecule , 2001, Molecular microbiology.

[32]  Christoph M Tang,et al.  Functional genomics of Neisseria meningitidis pathogenesis , 2000, Nature Medicine.

[33]  B. Barrell,et al.  Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491 , 2000, Nature.

[34]  W R Pearson,et al.  Comparison of DNA sequences with protein sequences. , 1997, Genomics.

[35]  X. Nassif,et al.  Interaction of Neisseria maningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC. , 1997, The Journal of infectious diseases.

[36]  J. Lowy,et al.  Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Ferguson,et al.  The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells , 1991, Molecular microbiology.

[38]  D. S. Kellogg,et al.  Neisseria gonorrhoeae II. Colonial Variation and Pathogenicity During 35 Months In Vitro , 1968, Journal of bacteriology.

[39]  N. Rouphael,et al.  Neisseria meningitidis: biology, microbiology, and epidemiology. , 2012, Methods in molecular biology.